Mechanisms of calcification in aortic valve disease: Role of mechanokinetics and mechanodynamics

Current Cardiology Reports

Volumn 15, Issue 5, 2013, Pages

  Merryman, W David ^a   Schoen, Frederick J ^b  

^a VANDERBILT UNIVERSITY   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Calcific aortic valve disease; Calcification; Mechanobiology; Mechanodynamics; Mechanokinetics

Indexed keywords

AORTA VALVE; AORTA VALVE DISEASE; BIOMECHANICS; CALCINOSIS; CONGENITAL HEART MALFORMATION; HUMAN; MECHANOTRANSDUCTION; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; VALVULAR HEART DISEASE;

AORTIC VALVE; BIOMECHANICS; CALCINOSIS; HEART DEFECTS, CONGENITAL; HEART VALVE DISEASES; HUMANS; MECHANOTRANSDUCTION, CELLULAR;

EID: 84884293121     PISSN: 15233782     EISSN: 15343170     Source Type: Journal    
DOI: 10.1007/s11886-013-0355-5     Document Type: Article

References (75)

1. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, et al. Heart disease and stroke statistics-2012 update: a report from the american heart association. Circulation. 2012;125:e2-e220.
2. Taking care: ethical caregiving in our aging society. The President's Council on Bioethics. 2005;309.
3. Schoen FJ. Mechanisms of function and disease of natural and replacement heart valves. Annu Rev Pathol. 2012;7:161-83.
4. Sacks MS, Merryman WD, Schmidt DE. On the biomechanics of heart valve function. J Biomech. 2009;42:1804-24.
5. Merryman WD. Mechano-potential etiologies of aortic valve disease. J Biomech. 2010;43:87-92.
6. Stephens EH, Chu CK, Grande-Allen KJ. Valve proteoglycan content and glycosaminoglycan fine structure are unique to microstructure, mechanical load, and age: Relevance to an age-specific tissue-engineered heart valve. Acta Biomater. 2008;4:1148-60.
7. Schoen F. Aortic valve structure-function correlations: role of elastic fibers no longer a stretch of the imagination. J Heart Valve Dis. 1997;6:1-6.
8. Butcher JT, Nerem RM. Porcine aortic valve interstitial cells in 3-dimensional culture: comparison of phenotype with aortic smooth muscle cells. J Heart Valve Dis. 2004;13:478-85.
9. Butcher JT, Nerem RM. Valvular endothelial cells and the mechanoregulation of valvular pathology. Philos Trans R Soc Lond B Biol Sci. 2007;362:1445-57. (Pubitemid 47195033)
10. Butcher JT, Penrod AM, Garcia AJ, Nerem RM. Unique morphology and focal adhesion development of valvular endothelial cells in static and fluid flow environments. Arterioscler Thromb Vasc Biol. 2004;24:1429-34. (Pubitemid 39050436)
11. Young EW, Wheeler AR, Simmons CA. Matrix-dependent adhesion of vascular and valvular endothelial cells in microfluidic channels. Lab Chip. 2007;7:1759-66. (Pubitemid 350145545)
12. Simmons CA, Grant GR, Manduchi E, Davies PF. Spatial heterogeneity of endothelial phenotypes correlates with side-specific vulnerability to calcification in normal porcine aortic valves. Circ Res. 2005;96:792-9. (Pubitemid 40559519)
13. Weinberg EJ, Mack PJ, Schoen FJ, Garcia-Cardena G, Kaazempur Mofrad MR. Hemodynamic environments from opposing sides of human aortic valve leaflets evoke distinct endothelial phenotypes in vitro. Cardiovasc Eng. 2010;10:5-11.
14. Liu AC, Joag VR, Gotlieb AI. The emerging role of valve interstitial cell phenotypes in regulating heart valve pathobiology. Am J Pathol. 2007;171:1407-18. (Pubitemid 350158303)
15. Taylor PM, Batten P, Brand NJ, Thomas PS, YacoubMH. The cardiac valve interstitial cell. Int J Biochem Cell Biol. 2003;35:113-8. (Pubitemid 35441268)
16. Hinz B. The myofibroblast: paradigm for a mechanically active cell. J Biomech. 2010;43:146-55.
17. Aikawa E, Whittaker P, Farber M, Mendelson K, Padera RF, Aikawa M, et al. Human semilunar cardiac valve remodeling by activated cells from fetus to adult: implications for postnatal adaptation, pathology, and tissue engineering. Circulation. 2006;113:1344-52. (Pubitemid 43739456)
18. Christie GW, Barratt-Boyes BG. Age-dependent changes in the radial stretch of human aortic valve leaflets determined by biaxial stretching. Ann Thorac Surg. 1995;60:S156-9.
19. Stephens EH, de Jonge N, McNeill MP, Durst CA, Grande-Allen KJ. Age-related changes in material behavior of porcine mitral and aortic valves and correlation to matrix composition. Tissue Eng Part A. 2010;16:867-78.
20. Wyss K, Yip CY, Mirzaei Z, Jin X, Chen JH, Simmons CA. The elastic properties of valve interstitial cells undergoing pathological differentiation. J Biomech. 2012;45:882-7.
21. Merryman WD, Youn I, Lukoff HD, Krueger PM, Guilak F, Hopkins RA, et al. Correlation between heart valve interstitial cell stiffness and transvalvular pressure: implications for collagen biosynthesis. Am J Physiol Heart Circ Physiol. 2006;290:H224-31.
22. Merryman WD, Lukoff HD, Long RA, Engelmayr Jr GC, Hopkins RA, Sacks MS. Synergistic effects of cyclic tension and transforming growth factor-beta1 on the aortic valve myofibroblast. Cardiovasc Pathol. 2007;16:268-76. (Pubitemid 47375116)
23. Balachandran K, Konduri S, Sucosky P, Jo H, Yoganathan AP. An ex vivo study of the biological properties of porcine aortic valves in response to circumferential cyclic stretch. Ann Biomed Eng. 2006;34:1655-65. (Pubitemid 44704821)
24. Balachandran K, Sucosky P, Jo H, Yoganathan AP. Elevated cyclic stretch alters matrix remodeling in aortic valve cusps: implications for degenerative aortic valve disease. Am J Physiol Heart Circ Physiol. 2009;296:H756-64.
25. Balachandran K, Sucosky P, Jo H, Yoganathan AP. Elevated cyclic stretch induces aortic valve calcification in a bone morphogenic protein-dependent manner. Am J Pathol. 2010;177:49-57.
26. Butcher JT, Nerem RM. Valvular endothelial cells regulate the phenotype of interstitial cells in co-culture: effects of steady shear stress. Tissue Eng. 2006;12:905-15. (Pubitemid 43726531)
27. El-Hamamsy I, Balachandran K, Yacoub MH, Stevens LM, Sarathchandra P, Taylor PM, et al. Endothelium-dependent regulation of the mechanical properties of aortic valve cusps. J Am Coll Cardiol. 2009;53:1448-55.
28. Schoen FJ, Mitchell RN. The heart. In: Kumar V, Fausto N, Aster JC, Abbas A, editors. Robbins/cotran pathologic basis of disease. 8th ed. Philadelphia: W.B. Saunders; 2010. p. 529-87.
29. Mohler III ER, Chawla MK, Chang AW, Vyavahare N, Levy RJ, Graham L, et al. Identification and characterization of calcifying valve cells from human and canine aortic valves. J Heart Valve Dis. 1999;8:254-60. (Pubitemid 29274326)
30. Rajamannan NM, Evans FJ, Aikawa E, Grande-Allen KJ, Demer LL, Heistad DD, et al. Calcific aortic valve disease: not simply a degenerative process: a review and agenda for research from the National Heart and Lung and Blood Institute Aortic Stenosis Working Group. Circulation. 2011;124:1783-91.
31. Gu X, Masters KS. Role of the Rho pathway in regulating valvular interstitial cell phenotype and nodule formation. Am J Physiol Heart Circ Physiol. 2011;300:H488-58.
32. Yip CY, Chen JH, Zhao R, Simmons CA. Calcification by valve interstitial cells is regulated by the stiffness of the extracellular matrix. Arterioscler Thromb Vasc Biol. 2009;29:936-42.
33. Schoen FJ, Levy RJ. Calcification of tissue heart valve substitutes: progress toward understanding and prevention. Ann Thorac Surg. 2005;79:1072-80. (Pubitemid 40288798)
34. Clark-Greuel JN, Connolly JM, Sorichillo E, Narula NR, Rapoport HS, Mohler III ER, et al. Transforming growth factor-beta1 mechanisms in aortic valve calcification: increased alkaline phosphatase and related events. Ann Thorac Surg. 2007;83:946-53. (Pubitemid 46328821)
35. Jian B, Narula N, Li QY, Mohler III ER, Levy RJ. Progression of aortic valve stenosis: TGF-beta1 is present in calcified aortic valve cusps and promotes aortic valve interstitial cell calcification via apoptosis. Ann Thorac Surg. 2003;75:457-65. discussion 65-6. (Pubitemid 36184488)
36. Proudfoot D, Skepper JN, Hegyi L, Bennett MR, Shanahan CM, Weissberg PL. Apoptosis regulates human vascular calcification in vitro: evidence for initiation of vascular calcification by apoptotic bodies. Circ Res. 2000;87:1055-62.
37. Fisher CI, Chen J, Merryman WD. Calcific nodule morphogenesis by heart valve interstitial cells is strain dependent. Biomech Model Mechanobiol. 2013;12:5-17.
38. David V, Martin A, Lafage-Proust MH, Malaval L, Peyroche S, Jones DB, et al. Mechanical loading down-regulates peroxisome proliferator-activated receptor gamma in bone marrow stromal cells and favors osteoblastogenesis at the expense of adipogenesis. Endocrinology. 2007;148:2553-62. (Pubitemid 47007541)
39. de Gorter DJ, van Dinther M, Korchynskyi O, Ten Dijke P. Biphasic effects of transforming growth factor-beta on bone morphogenetic protein-induced osteoblast differentiation. J Bone Miner Res. 2011;26:1178-87.
40. Hanson AD, Marvel SW, Bernacki SH, Banes AJ, van Aalst J, Loboa EG. Osteogenic effects of rest inserted and continuous cyclic tensile strain on hASC lines with disparate osteodifferentiation capabilities. Ann Biomed Eng. 2009;37:955-65.
41. Lomashvili KA, Cobbs S, Hennigar RA, Hardcastle KI, O'Neill WC. Phosphate-induced vascular calcification: role of pyrophosphate and osteopontin. J Am Soc Nephrol. 2004;15:1392-401. (Pubitemid 38679664)
42. Monzack EL, Masters KS. Can valvular interstitial cells become true osteoblasts? A side-by-side comparison. J Heart Valve Dis. 2011;20:449-63.
43. Rodriguez KJ, Masters KS. Regulation of valvular interstitial cell calcification by components of the extracellular matrix. J Biomed Mater Res A. 2009;90:1043-53.
44. Chen JH, Yip CY, Sone ED, Simmons CA. Identification and characterization of aortic valve mesenchymal progenitor cells with robust osteogenic calcification potential. Am J Pathol. 2009;174:1109-19.
45. Xu S, Gotlieb AI. Wnt3a/beta-catenin increases proliferation in heart valve interstitial cells. Cardiovasc Pathol. 2013 (in press).
46. Li C, Xu S, Gotlieb AI. The progression of calcific aortic valve disease through injury, cell dysfunction, and disruptive biologic and physical force feedback loops. Cardiovasc Pathol. 2013;22:1-8.
47. Han L, Gotlieb AI. Fibroblast growth factor-2 promotes in vitro heart valve interstitial cell repair through the Akt1 pathway. Cardiovasc Pathol. 2012;21:382-9.
48. Xu S, Liu AC, Kim H, Gotlieb AI. Cell density regulates in vitro activation of heart valve interstitial cells. Cardiovasc Pathol. 2012;21:65-73.
49. Engler AJ, Sen S, Sweeney HL, Discher DE. Matrix elasticity directs stem cell lineage specification. Cell. 2006;126:677-89. (Pubitemid 44233625)
50. Benton JA, Kern HB, Anseth KS. Substrate properties influence calcification in valvular interstitial cell culture. J Heart Valve Dis. 2008;17:689-99.
51. Gu X, Masters KS. Regulation of valvular interstitial cell calcification by adhesive peptide sequences. J Biomed Mater Res A. 2010;93:1620-30.
52. Wang H, Haeger SM, Kloxin AM, Leinwand LA, Anseth KS. Redirecting valvular myofibroblasts into dormant fibroblasts through light-mediated reduction in substrate modulus. PLoS One. 2012;7:e39969.
53. Hutcheson JD, Venkataraman R, Baudenbacher FJ, Merryman WD. Intracellular Ca(2+) accumulation is strain-dependent and correlates with apoptosis in aortic valve fibroblasts. J Biomech. 2012;45:888-94.
54. Otto CM. Calcific aortic valve disease: new concepts. Sem Thorac Cardiocvasc Surg. 2010;22:276-84.
55. Faggiano P, Antonini-Canterin F, Erlicher A, Romeo C, Cervesato E, Pavan D, et al. Progression of aortic valve sclerosis to aortic stenosis. Am J Cardiol. 2003;91:99-101. (Pubitemid 36050784)
56. Weinberg EJ, Schoen FJ, Mofrad MR.Acomputationalmodel of aging and calcification in the aortic heart valve. PLoS One. 2009;4:e5960.
57. Conti CA, Della Corte A, Votta E, Del Viscovo L, Bancone C, De Santo LS, et al. Biomechanical implications of the congenital bicuspid aortic valve: a finite element study of aortic root function from in vivo data. J Thorac Cardiovasc Surg. 2010;140:890-6.
58. Weinberg EJ, Kaazempur Mofrad MR. A multiscale computational comparison of the bicuspid and tricuspid aortic valves in relation to calcific aortic stenosis. J Biomech. 2008;41:3482-7.
59. Garg V, Muth AN, Ransom JF, Schluterman MK, Barnes R, King IN, et al. Mutations in NOTCH1 cause aortic valve disease. Nature. 2005;437:270-4. (Pubitemid 41294491)
60. Nigam V, Srivastava D. Notch1 represses osteogenic pathways in aortic valve cells. J Mol Cell Cardiol. 2009;47:828-34.
61. Yotsumato G, Iguro Y, Kinjo T, Matsumoto H, Masuda H, Sakata R. Congenital quadricuspid aortic valve: report of 9 surgical cases. Ann Thorac Cardiovasc Surg. 2003;9:134-7.
62. Tang Y-F, Xu J-B, Han L, Lu F-L, Lang X-L, Song Z-G, et al. Congenital quadricuspid aortic valve: analysis of 11 surgical cases. Ch Med J. 2011;124:2779-81.
63. Rajamannan NM, Edwards WD, Spelsberg TC. Hypercholesterolemic aortic-valve disease. N Engl J Med. 2003;349:717-8.
64. Rajamannan NM, SubramaniamM, Springett M, Sebo TC, Niekrasz M, McConnell JP, et al. Atorvastatin inhibits hypercholesterolemiainduced cellular proliferation and bone matrix production in the rabbit aortic valve. Circulation. 2002;105:2660-5. (Pubitemid 34596044)
65. Aronow WS, Ahn C, Kronzon I, Goldman ME. Association of coronary risk factors and use of statins with progression of mild valvular aortic stenosis in older persons. Am J Cardiol. 2001;88:693-5. (Pubitemid 32831111)
66. Novaro GM, Tiong IY, Pearce GL, Lauer MS, Sprecher DL, Griffin BP. Effect of hydroxymethylglutaryl coenzyme a reductase inhibitors on the progression of calcific aortic stenosis. Circulation. 2001;104:2205-9. (Pubitemid 33043301)
67. Rossebo AB, Pedersen TR, Boman K, Brudi P, Chambers JB, Egstrup K, et al. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. N Engl J Med. 2008;359:1343-56.
68. Teo KK, Corsi DJ, Tam JW, Dumesnil JG, Chan KL. Lipid lowering on progression of mild to moderate aortic stenosis: meta-analysis of the randomized placebo-controlled clinical trials on 2344 patients. Can J Cardiol. 2011;27:800-8.
69. Yip CY, BlaserMC, Mirzaei Z, ZhongX, Simmons CA. Inhibition of pathological differentiation of valvular interstitial cells by C-type natriuretic peptide. Arterioscler Thromb Vasc Biol. 2011;31:1881-9.
70. Thanassoulis G, Campbell CY, Owens DS, Smith JG, Smith AV, Peloso GM, et al. Genetic associations with valvular calcification and aortic stenosis. N Engl J Med. 2013;368:503-12.
71. Hutcheson JD, Setola V, Roth BL, Merryman WD. Serotonin receptors and heart valve disease-it was meant 2B. Pharmacol Ther. 2011;132:146-57.
72. Hutcheson JD, Ryzhova LM, Setola V, Merryman WD. 5-HT (2B) antagonism arrests non-canonical TGF-beta1-induced valvular myofibroblast differentiation. J Mol Cell Cardiol. 2012;53:707-14.
73. Ngo DT, Sverdlov AL, Horowitz JD. Prevention of aortic valve stenosis: a realistic therapeutic target? Pharmacol Ther. 2012;135:78-93.
74. Jaffre F, Bonnin P, Callebert J, Debbabi H, Setola V, Doly S, et al. Serotonin and angiotensin receptors in cardiac fibroblasts coregulate adrenergic-dependent cardiac hypertrophy. Circ Res. 2009;104:113-23.
75. Hutcheson JD, Chen J, Sewell-Loftin MK, Ryzhova LM, Fisher CI, Su YR, et al. Cadherin-11 regulates cell-cell tension necessary for calcific nodule formation by valvular myofibroblasts. Arterioscler Thromb Vasc Biol. 2013;33:114-20.